OUTLOOK THERAPEUTICS, INC. Debt Conversion, Converted Instrument, Amount
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Debt Conversion, Converted Instrument, Amount of $400.57 thousand for the 6-month period ending 2019-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2020-05-15
- OUTLOOK THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2017-12-31 was $1.41M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month |
|---|---|---|
| 2019-03-31 | $400.57K 10-Q · filed 2020-05-15 | |
| 2017-12-31 | $1.41M 10-Q · filed 2018-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |